Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$160.94
0.000.00%
Pre-Market: 4:34 PM EDT
Comments
Loading...
Inspire Medical Systems Analyst Ratings and Price Targets | NYSE:INSP | Benzinga
Inspire Medical Systems Inc has a consensus price target of $253.33 based on the ratings of 19 analysts. The high is $350 issued by Lake Street on August 2, 2023. The low is $181 issued by JP Morgan on October 17, 2023. The 3 most-recent analyst ratings were released by Truist Securities, RBC Capital, and Baird on February 11, 2025, respectively. With an average price target of $247.67 between Truist Securities, RBC Capital, and Baird, there's an implied 53.89% upside for Inspire Medical Systems Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
RBC Capital
Baird
Wells Fargo
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Inspire Medical Systems
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/11/2025 | Buy Now | 46.02% | Truist Securities | Richard Newitter74% | $250 → $235 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 61.55% | RBC Capital | Shagun Singh58% | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 02/11/2025 | Buy Now | 54.09% | Baird | Mike Polark55% | $252 → $248 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 21.16% | Wells Fargo | Larry Biegelsen69% | $198 → $195 | Maintains | Equal-Weight | Get Alert |
| 02/11/2025 | Buy Now | 36.7% | Morgan Stanley | Kallum Titchmarsh32% | $230 → $220 | Maintains | Overweight | Get Alert |
| 02/10/2025 | Buy Now | 44.77% | Piper Sandler | Adam Maeder65% | $260 → $233 | Maintains | Overweight | Get Alert |
| 01/24/2025 | Buy Now | 45.4% | Keybanc | Brett Fishbin51% | $236 → $234 | Reiterates | Overweight → Overweight | Get Alert |
| 01/21/2025 | Buy Now | 18.06% | Stifel | Jonathan Block73% | $200 → $190 | Maintains | Hold | Get Alert |
| 11/20/2024 | Buy Now | 58.44% | B of A Securities | Bob Hopkins48% | $220 → $255 | Upgrade | Neutral → Buy | Get Alert |
| 11/05/2024 | Buy Now | 61.55% | RBC Capital | Shagun Singh58% | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 11/05/2024 | Buy Now | 61.55% | Piper Sandler | Adam Maeder65% | $255 → $260 | Reiterates | Overweight → Overweight | Get Alert |
| 11/05/2024 | Buy Now | 24.27% | Stifel | Jonathan Block73% | $170 → $200 | Reiterates | Hold → Hold | Get Alert |
| 11/05/2024 | Buy Now | 23.03% | Wells Fargo | Larry Biegelsen69% | $187 → $198 | Maintains | Equal-Weight | Get Alert |
| 11/05/2024 | Buy Now | 56.58% | Baird | Mike Polark55% | $240 → $252 | Maintains | Outperform | Get Alert |
| 09/30/2024 | Buy Now | 49.12% | Truist Securities | Richard Newitter74% | $217 → $240 | Reiterates | Buy → Buy | Get Alert |
| 09/10/2024 | Buy Now | 22.41% | Leerink Partners | Mike Kratky66% | $167 → $197 | Maintains | Market Perform | Get Alert |
| 08/07/2024 | Buy Now | 46.64% | Keybanc | Brett Fishbin51% | $278 → $236 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | 61.55% | RBC Capital | Shagun Singh58% | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2024 | Buy Now | 24.27% | Baird | Mike Polark55% | $220 → $200 | Maintains | Outperform | Get Alert |
| 07/16/2024 | Buy Now | 34.83% | Truist Securities | Richard Newitter74% | $280 → $217 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 30.48% | Morgan Stanley | Kallum Titchmarsh32% | $250 → $210 | Maintains | Overweight | Get Alert |
| 06/24/2024 | Buy Now | 5.63% | Stifel | Jonathan Block73% | $210 → $170 | Maintains | Hold | Get Alert |
| 06/03/2024 | Buy Now | 14.95% | B of A Securities | Bob Hopkins48% | $225 → $185 | Maintains | Neutral | Get Alert |
| 05/08/2024 | Buy Now | 58.44% | Piper Sandler | Adam Maeder65% | $250 → $255 | Maintains | Overweight | Get Alert |
| 04/19/2024 | Buy Now | 77.08% | RBC Capital | Shagun Singh58% | → $285 | Initiates | → Outperform | Get Alert |
| 03/27/2024 | Buy Now | 55.34% | Mizuho | Anthony Petrone65% | $250 → $250 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 73.98% | Truist Securities | Richard Newitter74% | → $280 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | 55.34% | Morgan Stanley | Kallum Titchmarsh32% | → $250 | Initiates | → Overweight | Get Alert |
| 02/07/2024 | Buy Now | 73.98% | Truist Securities | Richard Newitter74% | $265 → $280 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | 55.34% | Mizuho | Anthony Petrone65% | $225 → $250 | Maintains | Buy | Get Alert |
| 02/06/2024 | Buy Now | 72.74% | Keybanc | Brett Fishbin51% | → $278 | Initiates | → Overweight | Get Alert |
| 01/19/2024 | Buy Now | 52.23% | Jefferies | — | → $245 | Initiates | → Buy | Get Alert |
| 01/02/2024 | Buy Now | 30.48% | Stifel | Jonathan Block73% | → $210 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | Buy Now | 61.55% | Truist Securities | Richard Newitter74% | $240 → $260 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | 16.19% | Wells Fargo | Larry Biegelsen69% | → $187 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | 30.48% | Stifel | Jonathan Block73% | $250 → $210 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 33.59% | Mizuho | Anthony Petrone65% | $300 → $215 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 49.12% | Truist Securities | Richard Newitter74% | $260 → $240 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 52.23% | Wells Fargo | Larry Biegelsen69% | $330 → $245 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | 55.34% | Stifel | Jonathan Block73% | $350 → $250 | Maintains | Buy | Get Alert |
| 10/17/2023 | Buy Now | 12.46% | JP Morgan | Robbie Marcus68% | $340 → $181 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | -1.21% | Leerink Partners | Mike Kratky66% | → $159 | Initiates | → Market Perform | Get Alert |
| 10/02/2023 | Buy Now | 111.26% | Truist Securities | Richard Newitter74% | → $340 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | 100.07% | UBS | Danielle Antalffy57% | $405 → $322 | Maintains | Buy | Get Alert |
| 08/24/2023 | Buy Now | 111.26% | Truist Securities | Richard Newitter74% | $363 → $340 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 111.26% | JP Morgan | Robbie Marcus68% | $300 → $340 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | 117.47% | Lake Street | Frank Takkinen41% | $305 → $350 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 125.55% | Truist Securities | Richard Newitter74% | $380 → $363 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 105.05% | Wells Fargo | Larry Biegelsen69% | $315 → $330 | Maintains | Overweight | Get Alert |
| 07/19/2023 | Buy Now | 136.11% | Truist Securities | Richard Newitter74% | $360 → $380 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 130.52% | Baird | Mike Polark55% | → $371 | Initiates | → Outperform | Get Alert |
| 07/13/2023 | Buy Now | 117.47% | Stifel | Jonathan Block73% | $300 → $350 | Maintains | Buy | Get Alert |
| 07/05/2023 | Buy Now | 120.58% | B of A Securities | Bob Hopkins48% | $310 → $355 | Maintains | Buy | Get Alert |
| 06/12/2023 | Buy Now | 86.4% | Mizuho | Anthony Petrone65% | → $300 | Reiterates | Buy → Buy | Get Alert |
| 06/08/2023 | Buy Now | 111.26% | Piper Sandler | Adam Mizrahi44% | $315 → $340 | Maintains | Overweight | Get Alert |
| 06/08/2023 | Buy Now | 108.15% | Keybanc | Matthew Mishan53% | $321 → $335 | Maintains | Overweight | Get Alert |
| 05/18/2023 | Buy Now | 123.69% | Piper Sandler | Adam Mizrahi44% | $335 → $360 | Maintains | Overweight | Get Alert |
| 05/03/2023 | Buy Now | 88.89% | UBS | Danielle Antalffy57% | $300 → $304 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 95.73% | Piper Sandler | Adam Mizrahi44% | $305 → $315 | Maintains | Overweight | Get Alert |
| 05/03/2023 | Buy Now | 99.45% | Keybanc | Matthew Mishan53% | $303 → $321 | Maintains | Overweight | Get Alert |
| 04/14/2023 | Buy Now | 86.4% | Mizuho | Anthony Petrone65% | → $300 | Initiates | → Buy | Get Alert |
| 04/13/2023 | Buy Now | 86.4% | Mizuho | Anthony Petrone65% | → $300 | Initiates | → Buy | Get Alert |
| 04/11/2023 | Buy Now | 86.4% | Stifel | Jonathan Block73% | $290 → $300 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | 86.4% | UBS | Danielle Antalffy57% | → $300 | Initiates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | 105.05% | Truist Securities | Richard Newitter74% | $310 → $330 | Maintains | Buy | Get Alert |
| 02/08/2023 | Buy Now | 86.4% | JP Morgan | Robbie Marcus68% | $271 → $300 | Maintains | Overweight | Get Alert |
| 02/08/2023 | Buy Now | 89.51% | Piper Sandler | Adam Maeder65% | $300 → $305 | Maintains | Overweight | Get Alert |
| 01/31/2023 | Buy Now | 92.62% | Truist Securities | Richard Newitter74% | $308 → $310 | Maintains | Buy | Get Alert |
| 01/26/2023 | Buy Now | 86.4% | Piper Sandler | Adam Maeder65% | $285 → $300 | Maintains | Overweight | Get Alert |
| 01/13/2023 | Buy Now | 88.27% | Keybanc | Matthew Mishan53% | $287 → $303 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | 91.38% | Truist Securities | Richard Newitter74% | $270 → $308 | Maintains | Buy | Get Alert |
| 12/13/2022 | Buy Now | — | Goldman Sachs | Amit Hazan56% | — | Upgrade | Neutral → Buy | Get Alert |
| 12/13/2022 | Buy Now | 78.33% | Keybanc | Matthew Mishan53% | → $287 | Initiates | → Overweight | Get Alert |
| 10/17/2022 | Buy Now | 49.12% | Truist Securities | Richard Newitter74% | $280 → $240 | Maintains | Buy | Get Alert |
| 08/03/2022 | Buy Now | 77.08% | Piper Sandler | Adam Maeder65% | $310 → $285 | Maintains | Overweight | Get Alert |
| 06/10/2022 | Buy Now | 55.34% | Truist Securities | Richard Newitter74% | $296 → $250 | Maintains | Buy | Get Alert |
| 04/13/2022 | Buy Now | 95.73% | Truist Securities | Richard Newitter74% | → $315 | Initiates | → Buy | Get Alert |
| 04/06/2022 | Buy Now | 67.76% | Wolfe Research | Mike Polark55% | → $270 | Initiates | → Peer Perform | Get Alert |
FAQ
What is the target price for Inspire Medical Systems (INSP) stock?
The latest price target for Inspire Medical Systems (NYSE:INSP) was reported by Truist Securities on February 11, 2025. The analyst firm set a price target for $235.00 expecting INSP to rise to within 12 months (a possible 46.02% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Inspire Medical Systems (INSP)?
The latest analyst rating for Inspire Medical Systems (NYSE:INSP) was provided by Truist Securities, and Inspire Medical Systems maintained their buy rating.
When was the last upgrade for Inspire Medical Systems (INSP)?
The last upgrade for Inspire Medical Systems Inc happened on November 20, 2024 when B of A Securities raised their price target to $255. B of A Securities previously had a neutral for Inspire Medical Systems Inc.
When was the last downgrade for Inspire Medical Systems (INSP)?
The last downgrade for Inspire Medical Systems Inc happened on January 2, 2024 when Stifel changed their price target from N/A to $210 for Inspire Medical Systems Inc.
When is the next analyst rating going to be posted or updated for Inspire Medical Systems (INSP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inspire Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inspire Medical Systems was filed on February 11, 2025 so you should expect the next rating to be made available sometime around February 11, 2026.
Is the Analyst Rating Inspire Medical Systems (INSP) correct?
While ratings are subjective and will change, the latest Inspire Medical Systems (INSP) rating was a maintained with a price target of $250.00 to $235.00. The current price Inspire Medical Systems (INSP) is trading at is $160.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.